Bkemv and Epysqli, Two Biosimilars of Soliris, are Now Available

Bkemv and Epysqli, Two Biosimilars of Soliris, are Now Available

Bkemv is being offered at 10% off Soliris, and Epysqli is offered at 30% below Soliris. Both biosimilars treat several of the same rare immune diseases as Soliris.

PBMs Innovating to Increase Biosimilar Use, Lower Rx Costs

Big Pharma Continues to Undermine Competition, Setting High Drug Prices to Boost Profits As the House Ways and Means Subcommittee on Health today holds a hearing on biosimilars, it’s important to highlight how pharmacy benefit companies are responding to changes in the market. PBMs are working with employers and other health plan sponsors to break down the barriers surrounding biosimilars and make them more accessible and affordable for patients…